Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.18 +0.10 (+2.33%)
As of: Nov 11, 2026 · 3:00 PM EST

Vanda Pharmaceuticals (VNDA) Net Equity Issued and Repurchased (2009 - 2022)

Updated

Vanda Pharmaceuticals (VNDA) reported Net Equity Issued and Repurchased of $605,000 for Q4 2022, down 44.5% from $1.09 million a year earlier.

Analysis

Vanda Pharmaceuticals (VNDA) Net Equity Issued and Repurchased (2009 - 2022) Analysis & Trends

For FY2022, Vanda Pharmaceuticals posted Net Equity Issued and Repurchased of $734,000, down 79.6% from FY2021.

  • Net Equity Issued and Repurchased has declined for four consecutive years, with a five-year compound annual growth rate of -32.7% (FY2017 to FY2022).
  • By year, Net Equity Issued and Repurchased came in at $3.6 million in FY2021 (-36.1%), $5.63 million in FY2020 (-10.6%), $6.3 million in FY2019 (-94.1%) and $107.17 million in FY2018.
  • Five-year quarterly Net Equity Issued and Repurchased spans a low of $4,000 in Q3 2022 and a high of $3.6 million in Q2 2020.
  • Year over year, Net Equity Issued and Repurchased has now declined in each of the last three quarters, with growth averaging 31.1% over the last seven quarters.
  • The high point for year-over-year Net Equity Issued and Repurchased in five years was Q4 2018 (growth of 515.4%); the low point was Q3 2022 (a decline of 98.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -377.00 Mn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -966.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -5.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -406.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 4.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -283.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Vanda Pharmaceuticals 246.71 Mn -529.97 Mn 65.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 605,000.00
Sep 30, 2022 4,000.00
Jun 30, 2022 125,000.00
Dec 31, 2021 1.09 Mn
Sep 30, 2021 371,000.00
Jun 30, 2021 289,000.00
Mar 31, 2021 1.85 Mn
Dec 31, 2020 1.43 Mn
Sep 30, 2020 102,000.00
Jun 30, 2020 3.60 Mn
Mar 31, 2020 500,000.00
Dec 31, 2019 2.15 Mn
Sep 30, 2019 548,000.00
Jun 30, 2019 3.40 Mn
Mar 31, 2019 200,000.00
Dec 31, 2018 800,000.00
Sep 30, 2018 100,000.00
Dec 31, 2017 130,000.00
Sep 30, 2017 768,000.00
Jun 30, 2017 2.19 Mn
API Access

Vanda Pharmaceuticals Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=VNDA&period=max&api_key=YOUR_API_KEY